This project began in April 2014 with a cohort of pregnant women scheduled to give birth at Hokkaido University Hospital. We invited them to participate in this study. All participants were asked to undergo echocardiographies at each of the trimesters of pregnancy, immediately postpartum within 1 week after childbirth (designated as “PP1”), 1 month after childbirth (postpartum day 23-39) (designated as “PP2”), and approximately at 3 months postpartum. In addition, we collected blood samples at the same time. Of 701 women with singleton and 61 with twin pregnancies who gave birth at the Hokkaido University Hospital during the 2-year study period, 151 and 41, respectively, participated in this project undergoing simultaneous echocardiographies and blood samplings (Fig.1). This study was conducted as an additional examination of our previous studies [11,22].
We conducted the study after receiving approval from the Institutional Review Board of Hokkaido University Hospital and participants provided voluntary written informed consent. This study abided by the Declaration of Helsinki.
Participants (Fig. 1) [11,22]
To compare longitudinal changes in echocardiographic findings between normotensive women with either singleton or twin pregnancy, we selected 22 twin pregnancies eligible participants meeting all of the following four criteria: (1) absence of preexisting hypertension or development of hypertension during the current pregnancy; (2) absence of preexisting diseases, including conditions involving hematological or endocrinological systems and connective tissue diseases; (3) uneventful clinical course during the current pregnancy; and (4) simultaneous echocardiography and blood sampling at least three times during the four stages of pregnancy/postpartum including the 2nd, 3rd, PP1, and PP2 timepoints. We selected two women with singleton pregnancies whose delivery date was closest to that of each woman with twin pregnancy meeting the above four criteria to serve as controls (44 women with singleton pregnancies in total).
Echocardiographic evaluations [11,22]
A single trained operator (TU) performed all the bedside transthoracic echocardiography with pregnant women in the left lateral decubitus position using the same machine (ProSound α7; Hitachi, Tokyo, Japan) according to the European Association of Cardiovascular Imaging guidelines [23]. We calculated the stroke volume as the product of the aortic valve area and the aortic flow velocity time integral. Only the inferior vena cava (IVC) diameter was evaluated in the dorsal position. To avoid any possible performance bias, the TU performed echocardiography blinded to the biochemical data.
Biochemical procedures [11,22]
Serum and plasma samples were stored at −20°C until assays of hs-TnI, NT-proBNP, BNP, and creatinine were ready to be performed. We used the following equation to obtain the estimated glomerular filtration rate (eGFR): 0.739 × 194 × serum creatinine – 1.094 × age [years] – 0.287 [24]. The hs-TnI, BNP, and NT-proBNP concentrations were measured using CIA kits (ARCHITECT High-Sensitivity Troponin I™, ARCHITECT BNP-JP™; Abbott Japan, Chiba, Japan; and Elecsys proBNP II STAT Assay™; Roche Diagnostics K.K., Tokyo, Japan, respectively).
Statistical Methods [11,22]
We performed all statistical analyses using JMP Pro12© (SAS, Cary, NC, USA) and the SPSS Statistics 24.0 software (IBM, Armonk, NY). We compared changes in variables within a group using Student’s t-test with Bonferroni’s correction. We used the mixed effect model to consider correlations at each time point and assess associations between echocardiographic parameters and biomarker levels. We standardized dependent (echocardiographic parameters) and independent (biomarker levels) variables to interpret the regression coefficient as the correlation coefficient. We implemented a compound symmetry covariance structure at each time point. For all analyses, we considered P<0.05 as indicating statistical significance. However, we defined a significant finding regarding a linear correlation between two standardized variables as that meeting both a P<0.05 and a standardized regression coefficient (β)>0.3 or <−0.3.